Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1233102.RAYOCOyhBmeBHUYRpNP444Nu5Ao0A0q5Fs81vdVnr0dTc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1233102.RAYOCOyhBmeBHUYRpNP444Nu5Ao0A0q5Fs81vdVnr0dTc130_assertion type Assertion NP1233102.RAYOCOyhBmeBHUYRpNP444Nu5Ao0A0q5Fs81vdVnr0dTc130_head.
- NP1233102.RAYOCOyhBmeBHUYRpNP444Nu5Ao0A0q5Fs81vdVnr0dTc130_assertion description "[Epidermal growth factor receptor overexpression is a predictive factor for trastuzumab response in HER2-positive primary breast cancer, but not in metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233102.RAYOCOyhBmeBHUYRpNP444Nu5Ao0A0q5Fs81vdVnr0dTc130_provenance.
- NP1233102.RAYOCOyhBmeBHUYRpNP444Nu5Ao0A0q5Fs81vdVnr0dTc130_assertion evidence source_evidence_literature NP1233102.RAYOCOyhBmeBHUYRpNP444Nu5Ao0A0q5Fs81vdVnr0dTc130_provenance.
- NP1233102.RAYOCOyhBmeBHUYRpNP444Nu5Ao0A0q5Fs81vdVnr0dTc130_assertion SIO_000772 25349977 NP1233102.RAYOCOyhBmeBHUYRpNP444Nu5Ao0A0q5Fs81vdVnr0dTc130_provenance.
- NP1233102.RAYOCOyhBmeBHUYRpNP444Nu5Ao0A0q5Fs81vdVnr0dTc130_assertion wasDerivedFrom befree-2016 NP1233102.RAYOCOyhBmeBHUYRpNP444Nu5Ao0A0q5Fs81vdVnr0dTc130_provenance.
- NP1233102.RAYOCOyhBmeBHUYRpNP444Nu5Ao0A0q5Fs81vdVnr0dTc130_assertion wasGeneratedBy ECO_0000203 NP1233102.RAYOCOyhBmeBHUYRpNP444Nu5Ao0A0q5Fs81vdVnr0dTc130_provenance.